TOP STORIES

• REGULATORY MHLW Struggling to Set Date for Chuikyo Subcommittee Discussions on Opdivo
  November 2, 2016

• BUSINESS Strong Yen Dampens Sales of 4 Japanese Majors, but Global Brands Keep Up Momentum
  November 2, 2016

• BUSINESS Daiichi Sankyo Earnings Lower on Yen Moves; Olmesartan Suffers 21.8% Slide
  November 1, 2016

• BUSINESS Takeda’s Half-Year Sales Slip on LLP Transfer, but Profits Zoom
  October 31, 2016

• BUSINESS Public “IP Platforms” Necessary for Startups: IPSN President
  October 28, 2016

• ORGANIZATION Realtor-Led Tokyo Life Sciences Hub Initiative Aims to Fill Void between Academia, Pharmas
  October 27, 2016

• BUSINESS AZ Japan Sees Combo Holding Promise in Immuno-Oncology Race, Set to Triple Oncology Sales in 5 Years
  October 26, 2016

• BUSINESS Wholesalers Hails Gilead Ambition to Unearth More Hep C Patients through Collaboration
  October 26, 2016

• BUSINESS Ono Files Patent Infringement Suit over Keytruda
  October 25, 2016

• REGULATORY Keytruda’s November Listing Skip Likely amid Opdivo Re-Pricing Fuss
  October 24, 2016

• BUSINESS Kipres Generics Might Add Bronchial Asthma Indication before December Listing
  October 21, 2016

• BUSINESS Kaketsuken’s Biz Transfer Talks Fall Apart, but Minister Nixes Its Continued Operations
  October 20, 2016

• BUSINESS Astellas Calls Off Biz Transfer Talks with Kaketsuken
  October 19, 2016

• REGULATORY Urgent Need for Rule on Interim NHI Price Revisions; Current System Unable to Respond in Case of Add’l Indications: MOF Budget Examiner
  October 19, 2016

• TRENDS Gilead Stays Pat on Hep C Plan, Japan Chief Says Innovation Outstrips Re-Pricing Hit
  October 18, 2016

• REGULATORY Govt Panel Member Pushes 50%-Plus Cut for Opdivo Price
  October 17, 2016

• BUSINESS Gilead Japan Trying to Dig Up Untreated Hep C Patients as Demand Ebbs
  October 14, 2016

• BUSINESS Takeda to Tighten R&D Focus, Strengthen Collaboration with Outside Parties; Main Challenge Will Be Financial
  October 13, 2016

• BUSINESS Interview: Teva Exec Says Takeda JV Can Grow Profit despite Generic Price Declines
  October 12, 2016

• BUSINESS Teva-Takeda JV Eyes Top Spot in Off-Patent Drug Market: CEO
  October 11, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 164
• 165
• 166
• 167
• 168
• 169
• 170
• 171
• 172
• …
• Next ›
• 最終 »